Odyssey Therapeutics
Odyssey Therapeutics is a biotechnology company focused on the development of next-generation immunomodulators and oncology medicines. By leveraging an integrated drug-hunting engine, the company aims to enhance the efficiency of drug discovery, unlocking high-potential targets while reducing the risk of attrition during the development process. Odyssey is committed to advancing precision medicine in the healthcare sector, with a product pipeline designed to facilitate a faster transition to clinical development, thereby improving treatment options for patients with various health conditions.
1 past transactions
Rahko
Acquisition in 2021
Rahko Limited is a company specializing in the development of a quantum machine learning (QML) software platform designed for chemical simulation. Founded in 2018 and headquartered in London, the company offers a platform that includes QML algorithms and tools aimed at enhancing accessibility to quantum computing. Rahko's technology facilitates advanced chemical simulations relevant to various industries, including batteries, materials, and pharmaceuticals. The company collaborates with leading quantum hardware manufacturers and major corporations, focusing on addressing real-world challenges that hold significant commercial value. With a team of experts in quantum machine learning, software engineering, and quantum chemistry, Rahko is recognized for its groundbreaking contributions to the field of quantum machine learning, particularly in advancing the capabilities of chemical simulations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.